The Infectious Diseases Society of America (IDSA)
has issued new guideline on the diagnosis and management of acute
bacterial rhinosinusitis, offering ways to distinguish bacterial from viral
infection and stressing that antibiotic treatment is not necessary in the
latter case.
Antibiotics kill bacteria, and are not
recommended for most sinus infections because 90% to 98% are caused by viruses.
An infection probably has a bacterial cause and
warrants antibiotics if symptoms last for at least 10 days and are not
improving; if symptoms are severe, such as a temperature of at least 102° and
facial pain for three to four successive days; and if symptoms worsen, usually
after a viral upper respiratory infection of five or six days' duration that seemed
to be improving, according to the guideline.
In patients who do have a bacterial sinus
infection, the guideline recommends amoxicillin-clavulanate (Augmentin) to
cover ampicillin resistant bacteria. Common antibiotics such as azithromycin
(Zithromax), clarithromycin (Biaxin) and trimethoprim-sulfamethoxazole (Septra)
are not recommended as first line antibiotics because of resistance issues. The
guideline also recommends that antibiotic treatment in adults last five to
seven days rather than 10 days to two weeks.
Whether viral or bacterial, sinus infections can
be miserable. Analgesics, such as ibuprofen or acetaminophen are excellent for
pain relief. Topical steroids (Flonase, Nasonex) have been shown to be
beneficial. Medications that thin mucus, such as guaifenesin (Mucinex) promote
drainage.
No comments:
Post a Comment